Continuation of Aspirin Therapy before Cataract Surgery with Different Incisions: Safe or Not?

Table 2

Systemic indication for antiplatelet therapy.

Systemic indication for antiplatelet therapy	Eyes, (%)		value
	Continuation group ()	Discontinuation group ()
Thromboembolic disease	84 (75.0)	82 (66.1)	0.136^a
Atrial fibrillation	4 (3.6)	7 (5.6)	0.450^a
Mechanical mitral	1 (0.9)	4 (3.2)	0.373^d
Coronary artery bypass graft	1 (0.9)	3 (2.4)	0.624^d
Cardiac pacemaker	1 (0.9)	2 (1.6)	1.000^d
Dilated cardiomyopathy	1 (0.9)	1 (0.9)	1.000^d
Precaution	20 (17.8)	25 (20.2)	0.653^a

Precaution = patients without certain systemic clinical indication; ^achi-square test; ^dFisher’s exact test.